Literature DB >> 10719165

The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies.

M Laruelle1.   

Abstract

Long-term sensitization is a process whereby exposure to a given stimulus such as a drug or a stressor results in an enhanced response at subsequent exposures. Sensitization of mesolimbic dopamine systems has been postulated by several authors to underlie the development of dopaminergic abnormalities associated with schizophrenia. In this review, core features of stimulant-induced sensitization of dopamine systems in rodents are briefly reviewed, as well as the behavioral and clinical evidence suggesting the relevance of this process to drug-induced psychosis and schizophrenia. Results of recent brain imaging studies relevant to the question of sensitization in schizophrenia are then discussed. These studies indicate that schizophrenia is associated with increased amphetamine-induced dopamine release. This exaggerated response was detected in patients experiencing an episode of clinical deterioration but not in clinically stable patients. Since increased stimulant-induced dopamine release is a hallmark of sensitization, these results support the view that schizophrenia is associated with a process of endogenous sensitization. Based on the preclinical evidence that dopamine projection to the prefrontal cortex acts as a buffer that oppose the development of sensitization in subcortical dopamine projections, we propose that, in schizophrenia, neurodevelopmental abnormalities of prefrontal dopaminergic systems might result in a state of enhanced vulnerability to sensitization during late adolescence and early adulthood. It is also proposed that D(2) receptor blockade, if sustained, might allow for an extinction of this sensitization process, with possible re-emergence upon treatment discontinuation. A better understanding of the neurocircuitry associated with endogenous sensitization and its consequence in schizophrenia might be important for the development of better treatment and relapse prevention strategies.

Entities:  

Mesh:

Year:  2000        PMID: 10719165     DOI: 10.1016/s0165-0173(99)00054-5

Source DB:  PubMed          Journal:  Brain Res Brain Res Rev


  72 in total

1.  Delayed mesolimbic system alteration in a developmental animal model of schizophrenia.

Authors:  Yukiori Goto; Patricio O'Donnell
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

2.  Psychostimulant-induced plasticity of intrinsic neuronal excitability in ventral subiculum.

Authors:  Donald C Cooper; Shannon J Moore; Nathan P Staff; Nelson Spruston
Journal:  J Neurosci       Date:  2003-10-29       Impact factor: 6.167

Review 3.  The role of rodent models in the discovery of new treatments for schizophrenia: updating our strategy.

Authors:  Holly Moore
Journal:  Schizophr Bull       Date:  2010-09-24       Impact factor: 9.306

4.  Of rats and schizophrenia.

Authors:  Patricia Boksa
Journal:  J Psychiatry Neurosci       Date:  2007-01       Impact factor: 6.186

5.  A comparison of regional brain volumes and white matter connectivity in subjects with stimulant induced psychosis versus schizophrenia.

Authors:  Peter D Alexander; Kristina M Gicas; Alex Cheng; Donna J Lang; Ric M Procyshyn; Alexandra T Vertinsky; William J Panenka; Allen E Thornton; Alexander Rauscher; Jamie Y X Wong; Tasha Chan; Andrea A Jones; F Vila-Rodriguez; William G Honer; Alasdair M Barr
Journal:  Psychopharmacology (Berl)       Date:  2019-06-22       Impact factor: 4.530

6.  Evidence that onset of clinical psychosis is an outcome of progressively more persistent subclinical psychotic experiences: an 8-year cohort study.

Authors:  M D G Dominguez; Marieke Wichers; Roselind Lieb; Hans-Ulrich Wittchen; Jim van Os
Journal:  Schizophr Bull       Date:  2009-05-21       Impact factor: 9.306

7.  In vivo evidence for greater amphetamine-induced dopamine release in pathological gambling: a positron emission tomography study with [(11)C]-(+)-PHNO.

Authors:  I Boileau; D Payer; B Chugani; D S S Lobo; S Houle; A A Wilson; J Warsh; S J Kish; M Zack
Journal:  Mol Psychiatry       Date:  2013-12-10       Impact factor: 15.992

8.  A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia.

Authors:  Holly Moore; J David Jentsch; Mehdi Ghajarnia; Mark A Geyer; Anthony A Grace
Journal:  Biol Psychiatry       Date:  2006-04-11       Impact factor: 13.382

9.  Transient disruption of attentional performance following escalating amphetamine administration in rats.

Authors:  Robyn L Kondrad; Joshua A Burk
Journal:  Psychopharmacology (Berl)       Date:  2004-10       Impact factor: 4.530

Review 10.  Does the concept of "sensitization" provide a plausible mechanism for the putative link between the environment and schizophrenia?

Authors:  Dina Collip; Inez Myin-Germeys; Jim Van Os
Journal:  Schizophr Bull       Date:  2008-01-18       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.